» Articles » PMID: 20232918

Xenobiotic Metabolism: a View Through the Metabolometer

Overview
Specialty Toxicology
Date 2010 Mar 18
PMID 20232918
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The combination of advanced ultraperformance liquid chromatography coupled with mass spectrometry, chemometrics, and genetically modified mice provide an attractive raft of technologies with which to examine the metabolism of xenobiotics. Here, a reexamination of the metabolism of the food mutagen PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine), the suspect carcinogen areca alkaloids (arecoline, arecaidine, and arecoline 1-oxide), the hormone supplement melatonin, and the metabolism of the experimental cancer therapeutic agent aminoflavone is presented. In all cases, the metabolic maps of the xenobiotics were considerably enlarged, providing new insights into their toxicology. The inclusion of transgenic mice permitted unequivocal attribution of individual and often novel metabolic pathways to particular enzymes. Last, a future perspective for xenobiotic metabolomics is discussed and its impact on the metabolome is described. The studies reviewed here are not specific to the mouse and can be adapted to study xenobiotic metabolism in any animal species, including humans. The view through the metabolometer is unique and visualizes a metabolic space that contains both established and unknown metabolites of a xenobiotic, thereby enhancing knowledge of their modes of toxic action.

Citing Articles

Sex-specific characterization of aortic function and inflammation in a new diet-induced mouse model of metabolic syndrome.

Tran V, Brettle H, Diep H, Figueiredo Galvao H, Fanson K, Sobey C FASEB J. 2025; 39(5):e70413.

PMID: 40035569 PMC: 11878204. DOI: 10.1096/fj.202401871R.


Synthesis of mono Cytochrome P450 in a modified CHO-CPR cell-free protein production platform.

Knauer J, Schulz C, Zemella A, Wustenhagen D, Walter R, Kupper J Sci Rep. 2024; 14(1):1271.

PMID: 38218994 PMC: 10787779. DOI: 10.1038/s41598-024-51781-6.


AhR, PXR and CAR: From Xenobiotic Receptors to Metabolic Sensors.

Rakateli L, Huchzermeier R, van der Vorst E Cells. 2023; 12(23).

PMID: 38067179 PMC: 10705969. DOI: 10.3390/cells12232752.


Immobilized Enzymes on Magnetic Beads for Separate Mass Spectrometric Investigation of Human Phase II Metabolite Classes.

Tsiara I, Riemer A, Correia M, Rodriguez-Mateos A, Globisch D Anal Chem. 2023; 95(33):12565-12571.

PMID: 37552796 PMC: 10456218. DOI: 10.1021/acs.analchem.3c02988.


Heritable Risk and Protective Genetic Components of Glaucoma Medication Non-Adherence.

Barr J, Feehan M, Tak C, Owen L, Finley R, Cromwell P Int J Mol Sci. 2023; 24(6).

PMID: 36982708 PMC: 10058353. DOI: 10.3390/ijms24065636.


References
1.
Wiegand R, Wu J, Sha X, LoRusso P, Heath E, Li J . Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate aminoflavone (NSC 686288) in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2009; 877(14-15):1460-4. PMC: 3762251. DOI: 10.1016/j.jchromb.2009.03.015. View

2.
Williams R . Detoxication mechanisms in man. Clin Pharmacol Ther. 1963; 4:234-54. DOI: 10.1002/cpt196342234. View

3.
Maharaj D, Maharaj H, Daya S, Glass B . Melatonin and 6-hydroxymelatonin protect against iron-induced neurotoxicity. J Neurochem. 2005; 96(1):78-81. DOI: 10.1111/j.1471-4159.2005.03532.x. View

4.
Meng L, Meng Z, Miao Z, Veenstra T, Pommier Y . Cytokeratin-RNA cross-linking mediated by the antitumor aminoflavone, 5-amino-2,3-fluorophenyl-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one. J Pharmacol Exp Ther. 2008; 325(2):674-80. DOI: 10.1124/jpet.108.137802. View

5.
Mortishire-Smith R, Castro-Perez J, Yu K, Shockcor J, Goshawk J, Hartshorn M . Generic dealkylation: a tool for increasing the hit-rate of metabolite rationalization, and automatic customization of mass defect filters. Rapid Commun Mass Spectrom. 2009; 23(7):939-48. DOI: 10.1002/rcm.3951. View